Pass the butter please. Email spam that actually haold your interest for a minute!

P ass The Butter … Please .  

           This is interesting . . . .  .
Margarine  was originally manufactured to fatten  turkeys.  When it [...]

FDA safety review Aprotinin( marked as trasylol)

Early Communication about an Ongoing Safety Review
Aprotinin Injection (marketed as Trasylol)
This information reflects FDA’s current analysis of available data concerning these drugs. Posting this information does not mean that FDA has concluded there is a causal relationship between the drug products and the emerging safety issue.  Nor does it mean that FDA is advising health [...]

Woolworths Fresh Future Children’s Hospital Appeal 2007 First Aid Kit

Woolworths Fresh Future Children’s Hospital Appeal 2007 First Aid Kit
Medical device recall

Level:
Consumer
Class:
I

Reference:
RN-2007-0610
Date:
31 August 2007

Product:
Woolworths Fresh Future Children’s Hospital Appeal 2007 First Aid Kit

ARTG number:
136299

Batch number:
All batches

Sponsor:
The Promotional Shop Pty Ltd

Phone:
1800 732 372

Reason:
Microbial contamination of the antiseptic wipes contained in the first aid kits.

Letters are expected to be dispatched by the sponsor within two [...]

This Alert highlights important emerging safety information about Rituxan.

FDA ALERT [12/18/2006] This Alert highlights important emerging safety information about Rituxan. Two patients have died after being treated [...]

Australian adverse drug reaction bulletin August 2007 TGA australia. Please viist this web site for accurate and up to date info. Copy and pasted by Dom for your information. Please follow through with your own questions?

Australian Adverse Drug Reactions Bulletin
Volume 26, Number 4, August 2007
Prepared by the Adverse Drug Reactions Advisory Committee (ADRAC).
Contents

Rituximab and progressive multifocal leukoencephalopathy
Implanon: interactions and failure of contraception
Atypical antipsychotic agents and extrapyramidal side effects
Subscribe to the Bulletin on-line
Drugs of current interest
What to report

Printable version of this bulletin (pdf,35kb)
Rituximab and progressive multifocal leukoencephalopathy
ADRAC has received a report [...]

TGA australia Urgent advice re management of patients taking prexige. My question is why haven’t I seen this in the media as a feature since the recall on Sat here in Aussie? Please explain? Doesn’t the TGA message get out? Or is there some policy in place to supress this info from the general pulic? here , here , that can’t be the case , so whats going on? What do you think?

Urgent advice regarding management of patients taking lumiracoxib (Prexige)
Safety alert
13 August 2007

ALL patients should stop taking Lumiracoxib immediately.
ALL patients should be assessed by their doctor for any clinical or biochemical evidence of liver damage.

Lumiracoxib (tradename Prexige) was approved for the indications:

Symptomatic relief in the treatment of osteoarthritis.
Relief of acute pain, including post-operative pain and pain [...]

Australian Children targeted with junk food advertising.

Australian children targeted with junk food advertising
FOR IMMEDIATE RELEASE
==========================================================================================================
17th April 2007, Cambridge, England, UK & New York, USA
Forthcoming article in Public Health Nutrition calls for restriction on food advertising to children in Australia
A study from the University of Sydney published in the international journal Public Health Nutrition, shows food companies are increasingly targeting young people [...]

TGA Australia Urgent recall Lumiracoxib PREXIGE medicine. Visit www.tga.gov.au for more information.

Medicines Regulator cancels registration of anti inflammatory drug, Lumiracoxib
Media statement
11 August 2007
Australia’s medicines Regulator, the Therapeutic Goods Administration (TGA) has cancelled the registration of the osteoarthritis drug, Lumiracoxib because of serious liver side effects associated with the use of the drug.
Lumiracoxib, marketed by Novartis Pharmaceuticals under the brand name of Prexige, is a Cox 2 inhibitor [...]

Medicine agency Bill New Zealand Herald today. Do you think NZ should join Australia in this policy?

Key says he’ll back medicines agency bill
5:00AM Wednesday August 01, 2007
By Audrey Young

John Key states he will sign a compromise proposal to regulate medicines in New Zealand.

Related nzherald links:

Audrey Young’s blog

National Party leader John Key says he will sign up to the two-tiered compromise proposal on a transtasman therapeutics agency, a [...]

vioxx danger begins earlier than stated. Reuters latest article today. What do you think of this?

Study says Vioxx danger begins earlier than stated
Thu Jul 26, 2007 3:15AM EDT
By Bill Berkrot
NEW YORK (Reuters) - The increased heart risk from Vioxx, Merck & Co’s withdrawn arthritis medicine, begins much earlier than after 18 months of use, according to a study that contradicts assertions by the drug maker and its scientists.
The 2,434-patient study, [...]